Wells Fargo Maintains Equal-Weight on Mantech Intl, Raises Price Target to $91
Wells Fargo analyst Matthew Akers maintains Mantech Intl (NASDAQ:MANT) with a Equal-Weight and raises the price target from $89 to $91.
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Wells Fargo Maintains Equal-Weight on Mantech Intl, Raises Price Target to $89
Wells Fargo analyst Matthew Akers maintains Mantech Intl (NASDAQ:MANT) with a Equal-Weight and raises the price target from $77 to $89.
ManTech Shares Spike To Session High On Volume As Seeing Bloomberg Report Citing Reuters Veritas, Leidos Among Parties Interested In Co.; BZ NOTE: Benzinga Newsdesk Does Not See This Report On Reuters
https://twitter.com/faststocknewss/status/1502022962404233219
Earnings Scheduled For February 23, 2022
Companies Reporting Before The Bell
• Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter.
Merger Monday: 4 M&A Rumors Investors Are Focused On This Week
Peloton Interactive Inc (NASDAQ: PTON) climbed more than 20% Monday with rumors of the fitness equipment manufacturer finding a potential suitor. The stock has recently been hit with a flurry of sp
Why Are Mantech International Shares Soaring Today?
BofA analyst Mariana Perez Mora double upgraded Mantech International Corp (NASDAQ:MANT) to Buy from Underperform and raised the price target to $90, from $75.…
Morgan Stanley Maintains Equal-Weight on Mantech Intl, Lowers Price Target to $83
Morgan Stanley analyst Matthew Sharpe maintains Mantech Intl (NASDAQ:MANT) with a Equal-Weight and lowers the price target from $92 to $83.
